Loading clinical trials...

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report | Clinical Trials | Clareo Health

COMPLETEDPHASE1

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report From June 2015 to June 2016

NCT02955862•National Hospital for Tropical Diseases, Hanoi, Vietnam

View on ClinicalTrials.gov

Summary

CRICS financial report for the first budget year of the study

Detailed Description

Vietnam Cryptococcal Retention in Care Study (CRICS) federal financial report for the first budget year of the study

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Aged ≥ 18 years
•Confirmed HIV infection using National Testing Algorithm
•CD4 ≤100 cells/μL
•Able to provide written informed consent

Exclusion Criteria

•History of prior CM
•Receipt of systemic antifungal medication for more than 4 consecutive weeks within the past 6 months
•Currently taking ART or history of ART for more than 4 weeks within the past year
•Known to be currently pregnant or planning to become pregnant during the study period

Locations (1)

National hospital for tropical diseases

Ham Zong, Vietnam

Key Dates

Start Date

June 1, 2015

Primary Completion Date

September 1, 2017

Completion Date

September 1, 2017

Last Updated

March 29, 2018

Enrollment

1,177

ACTUAL participants

Conditions

Cryptococcal Meningitis

Interventions

Vietnam Cryptococcal Retention in Care Study (CRICS)

OTHER

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

NCT05685641

Acquired Immunodeficiency SyndromeHistoplasmosis AIDS+2 more

View study

COMPLETEDPHASE3

Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis

NCT01802385

Cryptococcal MeningitisFungal Meningitis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 29, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report

Inclusion Criteria

Exclusion Criteria

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis

Operational Research for Cryptococcal Antigen Screening

CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis